Treatment primary nocturnal enuresis oral androgen mesterolone clinical cystometric study double-blind clinical study boys years age primary nocturnal enuresis role androgens enuresis oral synthetic androgen mesterolone minimal potential toxic effects boys mesterolone placebo Fourteen dry treatment mg days dry follow-up period months cystometric bladder capacity disappearance uninhibited detrusor contractions significant number cases treatment side effects Mesterolone autonomic innervation vesical musculature correction defective neural mechanism pathogenesis nocturnal enuresis 